Enzymotec debuts edible oil designed to fight "bad
MultOil combines health benefits with functionality for a wide range ofapplications such as oils, spreads, mayonnaise and salad dressing. MultOilis a family of multi-functional oils, based on natural oils enriched withphytosterols and DAG to synergistically reduce the risk for CHD. It is acombination of 25% phytosterol-ester (PS-E) and 15% diglycerides (DAG).PS-E and DAG are widely known to reduce the risk for coronary heartdisease. The FDA has recognized them as GRAS, and most importantly,products containing PS-E are allowed to be label as reducing the risk forcoronary heart disease.
MultOil is produced from a patented process called AMIET®, a breakouttechnology, developed by Enzymotec, which is an enzyme modificationprocess. This exclusive technology enables regular enzymes to perform in anon-aqueous media, with high activity and recycleability without loosingtheir specificity or selectivity. Therefore, MultOil could be used indeferent oils, spreads and sauces applications.
"MultOil enables oil producers to introduce trans fat free oil to thefunctionalfoods market, based on advance technology," explains Dr. ArielKatz, Enzymotec’s CEO. "Furthermore, it offers new opportunities to oilproducers and strengthen their market position. "
MultOil could be used either as a substitute to cooking oil or as abeneficial ingredient in food formulations such as spreads or saladdressings. Additionally, MultOil could be used in deferent forms likeliquid; solid and semi-liquid, which creates competitive edge for spreads,salad dressings, and mayonnaise producers that currently, market brandswith unhealthy image.
All the ingredients in MultOil, the phytosterols and the enzyme are Koshercertified and produced from non–GMO ingredients.
Enzymotec is an emerging developer of advanced, market-driven products forthe nutraceutical market, founded in 1998, in the north of Israel.Enzymotec is specialized in phospholipids, structured triglycerides andsterol modification; all of them are the most prominent developmentcategories in lipid chemistry.
Contact:
Elzaphan Hotam,Business Development Manager,EnzymotecTel: 972-4-6545112Fax: 972-4-6443799E-mail: info@enzymotec.comURL: http://www.enzymotec.com